Abstract:This study reports the successful synthesis of core-shell microparticles utilizing coaxial electrospray techniques, with zeolitic imidazolate framework-8 (ZIF-8) encapsulating rhodamine B (RhB) in the core and a phase change material (PCM) shell composed of a eutectic mixture of lauric acid (LA) and stearic acid (SA). ZIF-8 is well-recognized for its pH-responsive degradation and biocompatibility, making it an ideal candidate for targeted drug delivery. The LA-SA PCM mixture, with a melting point near physiological temperature (39 °C), enables temperature-triggered drug release, enhancing therapeutic precision. The structural properties of the microparticles were extensively characterized through scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). Drug release studies revealed a dual-stimuli response, where the release of RhB was significantly influenced by both temperature and pH. Under mildly acidic conditions (pH 4.0) at 40 °C, a rapid and complete release of RhB was observed within 120 h, while at 37 °C, the release rate was notably slower. Specifically, the release at 40 °C was 79% higher than at 37 °C, confirming the temperature sensitivity of the system. Moreover, at physiological pH (7.4), minimal drug release occurred, demonstrating the system's potential for minimizing premature drug release under neutral conditions. This dual-stimuli approach holds promise for improving therapeutic outcomes in cancer treatment by enabling precise control over drug release in response to both pH and localized hyperthermia, reducing off-target effects and improving patient compliance.

A Porous Zn-based Metal-Organic Framework for Ph and Temperature Dual-Responsive Controlled Drug Release

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Controlled Zn2+-Triggered Drug Release by Preferred Coordination of Open Active Sites Within Functionalization Indium Metal Organic Frameworks.

A biocompatible metal-organic framework as a pH and temperature dual-responsive drug carrier.

Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.

Recent Developments On Zinc(Ii) Metal-Organic Framework Nanocarriers For Physiological Ph-Responsive Drug Delivery

A Porphyrin-Based Metal–organic Framework As a Ph-Responsive Drug Carrier

A Biocompatible Ti-based Metal-Organic Framework for Ph Responsive Drug Delivery

Engineering pH and Temperature-Triggered Drug Release with Metal-Organic Frameworks and Fatty Acids

Hollow Mesoporous Silica@Metal-Organic Framework and Its Applications for pH-Responsive Doxorubicin Drug Delivery.

Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution

A Low Cytotoxic Cationic Metal-Organic Framework Carrier for Controllable Drug Release

One-pot Synthesis of Metal–Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery

Coordination polymer nanocapsules prepared using metal–organic framework templates for pH-responsive drug delivery

Selenium-containing Polymer@metal-Organic Frameworks Nanocomposites As an Efficient Multi-Responsive Drug Delivery System

Bifunctional Therapy by Zinc‐Cobalt Bimetal‐Organic Framework with Encapsulated Doxorubicin to Overcome Drug‐Resistance

Pressure Controlled Drug Release in a Zr-cluster-based MOF

Temperature Treatment of Highly Porous Zirconium-Containing Metal-Organic Frameworks Extends Drug Delivery Release.

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy

Environment Responsive Metal–Organic Frameworks as Drug Delivery System for Tumor Therapy

Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for Ph and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.